These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11422216)

  • 1. Ouabain-induced coronary vasoconstriction in cats is not neurally mediated.
    Nair BA; Murad YZ; Brody MJ; Gutterman DD
    Clin Exp Pharmacol Physiol; 2001 Jul; 28(7):510-7. PubMed ID: 11422216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ouabain induced primary coronary vasoconstriction. 1.
    Bloor CM; Walker DE; Pensinger RR
    Proc Soc Exp Biol Med; 1972 Sep; 140(4):1409-13. PubMed ID: 5057605
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of nitric oxide synthesis augments centrally induced sympathetic coronary vasoconstriction in cats.
    Goodson AR; Leibold JM; Gutterman DD
    Am J Physiol; 1994 Oct; 267(4 Pt 2):H1272-8. PubMed ID: 7943371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of a central adrenergic mechanism in the cardiovascular responses to ouabain.
    Saxena PR; Bhargava KP
    Eur J Pharmacol; 1975 Apr; 31(2):332-46. PubMed ID: 1056858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of stellate ganglionectomy on basal cardiovascular function and responses to beta1-adrenoceptor blockade in the rat.
    Yoshimoto M; Wehrwein EA; Novotny M; Swain GM; Kreulen DL; Osborn JW
    Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2447-54. PubMed ID: 18931026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation in the region of parabrachial nucleus elicits neurogenically mediated coronary vasoconstriction.
    Miller FJ; Marcus ML; Brody MJ; Gutterman DD
    Am J Physiol; 1991 Nov; 261(5 Pt 2):H1585-96. PubMed ID: 1683174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compared peripheral vascular responses to intravenous and intra-arterial administrations of positive inotropic agents in conscious dogs.
    Gosgnach M; Gérard JL; Berdeaux A; Giudicelli JF
    Fundam Clin Pharmacol; 1991; 5(8):709-18. PubMed ID: 1783360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous phentolamine abolishes coronary vasoconstriction in response to mild central hypovolemia.
    Gao Z; Muller MD; Sinoway LI; Leuenberger UA
    J Appl Physiol (1985); 2014 Jan; 116(2):216-21. PubMed ID: 24311747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of coronary vasoconstrictor site in medullary reticular formation.
    Gutterman DD; Bonham AC; Arthur JM; Gebhart GF; Marcus ML; Brody MJ
    Am J Physiol; 1989 Apr; 256(4 Pt 2):H1218-27. PubMed ID: 2565092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurogenic regulation of coronary blood flow: evidence for a central nervous system pathway.
    Bonham AC; Gutterman DD; Arthur JM; Marcus ML; Gebhart GF; Brody MJ
    Circ Res; 1987 Nov; 61(5 Pt 2):II42-6. PubMed ID: 2444359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of parabrachial nucleus in baroreflex-mediated coronary vasoconstriction.
    Gutterman DD; Goodson A
    Am J Physiol; 1996 Sep; 271(3 Pt 2):H1079-86. PubMed ID: 8853344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ouabain on large coronary artery diameter.
    Schwartz JS; Bache RJ
    J Cardiovasc Pharmacol; 1988 May; 11(5):608-13. PubMed ID: 2455848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and chronic cardiac and regional haemodynamic effects of the novel bradycardic agent, S16257, in conscious rats.
    Gardiner SM; Kemp PA; March JE; Bennett T
    Br J Pharmacol; 1995 Jun; 115(4):579-86. PubMed ID: 7582475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposing responses in sympathetic nerve activity induced by central injections of ouabain.
    Weaver LC; Akera T; Brody TM
    J Pharmacol Exp Ther; 1975 Oct; 195(1):114-25. PubMed ID: 1102662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart rate variability in conscious neonatal swine: spectral features and responses to short-term intermittent hypoxia.
    Sica AL; Zhao N
    BMC Physiol; 2006 Jun; 6():5. PubMed ID: 16780581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary arteriolar vasoconstriction in myocardial ischaemia: reflexes, sympathetic nervous system, catecholamines.
    Longhurst JC
    Eur Heart J; 1990 Apr; 11 Suppl B():43-52. PubMed ID: 2364955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonuniform cardiac sympathetic nerve discharge: mechanism for coronary occlusion and digitalis-induced arrhythmia.
    Lathers CM; Kelliher GJ; Roberts J; Beasley AB
    Circulation; 1978 Jun; 57(6):1058-65. PubMed ID: 639225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of ouabain and propranolol in the central nervous system. Neurally-mediated effects on the cardiovascular system.
    Sivam SP; Seth SD; Nayar U; Manchanda SC
    Pharmacology; 1982; 25(5):286-93. PubMed ID: 7178228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic and myocardial energetic effects of CK-3197, a selective positive inotropic agent.
    Greenberg S; Touhey B
    J Cardiovasc Pharmacol; 1991 Jan; 17(1):145-53. PubMed ID: 1708048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ouabain on in situ cardiac sympathetic nerve endings.
    Yamazaki T; Akiyama T; Kawada T
    Neurochem Int; 1999 Dec; 35(6):439-45. PubMed ID: 10524711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.